Cosmos Health targets 2029 revenue of $200.6 million, gross profit of $71.2 million
Bitget2026/09/28 13:06- Cosmos Health reiterated 2029 targets of USD 200.6 million revenue, USD 71.2 million gross profit, citing contract manufacturing as a key driver.
- Contract manufacturing pipeline at Cana Laboratories exceeded USD 20 million implied revenue, implying over USD 18 million gross profit at over 90% margins.
- Management estimates the current pipeline equates to about USD 5 million implied annual revenue, about USD 4.5 million implied annual gross profit.
- Production pipeline reached 32,700,000 units, up about sixfold since mid-2024, supporting a goal of over USD 10 million recurring annual gross profit.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Only twice in history! S&P 500 equal-weight index is expected to record seven consecutive weeks of decline this week
The S&P 500 Equal Weight Index is expected to fall for a seventh consecutive week. If this downward trend continues through Friday, it will mark only the third time in history that the index has experienced seven straight weeks of decline.
Trump “bites” Powell, demanding his resignation from the Federal Reserve Board, citing severe cost overruns in headquarters renovation.
U.S. President Trump on Wednesday called for former Federal Reserve Chairman Powell to resign from his position as a Fed governor, following an inspector general report on the Federal Reserve headquarters renovation project, which highlighted a series of management issues that led to significant cost overruns.
Gladstone Investment Closes Acquisition of Extrude Hone